Association between SDF1-3′A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases
- 11 October 2012
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 39 (12) , 11073-11079
Abstract
In the present study, we aimed to investigate the association between SDF1-3′A and CXCR4 gene polymorphisms and the susceptibility and clinicopathological development of prostate cancer. SDF1-3′A and CXCR4 gene polymorphisms were assessed by polymerase chain reaction restriction-fragment length polymorphism (PCR–RFLP) in 149 healthy subjects and 152 patients with prostate cancer. There were no significant differences in the distributions of SDF-1 and CXCR4 genotypes between controls and prostate cancer patients. However, the patients with AA genotype of SDF1-3′A gene presented a higher risk for developing an advanced disease status as compared to patients with GG homozygotes (aOR = 2.02; 95 % CI = 1.05-3.90; P = 0.035). In addition, the distribution of AA genotype of SDF1-3′A gene was found significantly increased in the patients with bone metastasis in comparison to those without bone metastasis (aOR = 2.94; 95 % CI = 1.26-6.82; P = 0.012). On the other hand, CXCR4 gene polymorphism was not associated with the clinicopathological characteristics of prostate cancer. Our results suggest that SDF1-3′A and CXCR4 gene polymorphisms may not be risk factors for the susceptibility to prostate cancer. However, SDF1-3′A gene polymorphism may be associated with the progression and bone metastasis of prostate cancer in a Turkish men population.Keywords
This publication has 44 references indexed in Scilit:
- CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancyProceedings of the National Academy of Sciences, 2010
- Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case–control studyInternational Journal of Immunogenetics, 2009
- Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological studyThe Lancet Oncology, 2008
- Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort studyThe Lancet Oncology, 2008
- Chemokines in tumor angiogenesis and metastasisCancer and Metastasis Reviews, 2007
- Inflammation in prostate carcinogenesisNature Reviews Cancer, 2007
- CXCR4 Chemokine Receptor Mediates Prostate Tumor Cell Adhesion through α5 and β3 IntegrinsNeoplasia, 2006
- Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrixLife Sciences, 2006
- Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinomaLaboratory Investigation, 2004
- CXCR4 and CXCL12 (SDF-1) in Prostate CancerClinical Cancer Research, 2004